Sex steroid hormone effects in normal and pathologic conditions in lung physiology

Mini-Reviews in Medicinal Chemistry

Volumn 12, Issue 11, 2012, Pages 1055-1062

  Gonzalez Arenas A ^a   Agramonte Hevia, J ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Estradiol; Estrogen receptor; Lung; Progesterone; Progesterone receptor

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; PROGESTERONE; SEX HORMONE;

ASTHMA; CARBON DIOXIDE TENSION; CYSTIC DISEASE; FETUS LUNG MATURATION; HORMONE ACTION; HUMAN; LUNG CANCER; LUNG DEVELOPMENT; LUNG DISEASE; LUNG FUNCTION; MENSTRUAL CYCLE; NONHUMAN; PREGNANCY; REVIEW; VASOCONSTRICTION; VASODILATATION;

ANIMALS; ASTHMA; GONADAL STEROID HORMONES; HUMANS; LUNG; LUNG NEOPLASMS; LYMPHANGIOLEIOMYOMATOSIS;

EID: 84867007232     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/138955712802762194     Document Type: Review

References (104)

1. Brodeur, P.; Mockus, M.; McCullough, R.; Moore, L. G., Progesterone receptors and ventilatory stimulation by progestin. J. Appl. Physiol., 1986, 60, (2), 590-595.
2. Hosenpud, J. D.; Hart, M. V.; Morton, M. J.; Hohimer, A. R.; Resko, J. A., Progesterone-induced hyperventilation in the guinea pig. Respir. Physiol., 1983, 52, (2), 259-264.
3. Massaro, G. D.; Mortola, J. P.; Massaro, D., Estrogen modulates the dimensions of the lung's gas-exchange surface area and alveoli in female rats. Am. J. Physiol., 1996, 270, (1 Pt 1), L110-114.
4. Pickett, C. K.; Regensteiner, J. G.; Woodard, W. D.; Hagerman, D. D.; Weil, J. V.; Moore, L. G., Progestin and estrogen reduce sleepdisordered breathing in postmenopausal women. J. Appl. Physiol., 1989, 66, (4), 1656-1661.
5. Regensteiner, J. G.; Woodard, W. D.; Hagerman, D. D.; Weil, J. V.; Pickett, C. K.; Bender, P. R.; Moore, L. G., Combined effects of female hormones and metabolic rate on ventilatory drives in women. J. Appl. Physiol., 1989, 66, (2), 808-813.
6. Tatsumi, K.; Mikami, M.; Kuriyama, T.; Fukuda, Y., Respiratory stimulation by female hormones in awake male rats. J. Appl. Physiol., 1991, 71, (1), 37-42.
7. Torday, J. S.; Dow, K. E., Synergistic effect of triiodothyronine and dexamethasone on male and female fetal rat lung surfactant synthesis. Dev. Pharmacol. Ther., 1984, 7, (2), 133-139.
8. Goodland, R. L.; Pommerenke, W. T., Cyclic fluctuations of the alveolar carbon dioxide tension during the normal menstrual cycle. Fertil Steril, 1952, 3, (5), 394-401.
9. Goodland, R. L.; Reynolds, J. G.; Pommerenke, W. T., Alveolar carbon dioxide tension levels during pregnancy and early puerperium. J. Clin. Endocrinol. Metab., 1954, 14, (5), 522-530.
10. Johannesson, M.; Ludviksdottir, D.; Janson, C., Lung function changes in relation to menstrual cycle in females with cystic fibrosis. Respir. Med., 2000, 94, (11), 1043-1046.
11. Earley, S.; Resta, T. C., Estradiol attenuates hypoxia-induced pulmonary endothelin-1 gene expression. Am. J. Physiol. Lung Cell Mol. Physiol., 2002, 283, (1), L86-93.
12. Gonzales, R. J.; Walker, B. R.; Kanagy, N. L., 17beta-estradiol increases nitric oxide-dependent dilation in rat pulmonary arteries and thoracic aorta. Am. J. Physiol. Lung Cell Mol. Physiol., 2001, 280, (3), L555-564.
13. Sylvester, J. T.; Gordon, J. B.; Malamet, R. L.; Wetzel, R. C., Prostaglandins and estradiol-induced attenuation of hypoxic pulmonary vasoconstriction. Chest, 1985, 88, (4 Suppl), 252S-254S.
14. Cuzzocrea, S.; Mazzon, E.; Sautebin, L.; Serraino, I.; Dugo, L.; Calabro, G.; Caputi, A. P.; Maggi, A., The protective role of endogenous estrogens in carrageenan-induced lung injury in the rat. Mol. Med., 2001, 7, (7), 478-487.
15. MacGregor, J. I.; Jordan, V. C., Basic guide to the mechanisms of antiestrogen action. Pharmacol. Rev., 1998, 50, (2), 151-196.
16. Lindberg, M. K.; Weihua, Z.; Andersson, N.; Moverare, S.; Gao, H.; Vidal, O.; Erlandsson, M.; Windahl, S.; Andersson, G.; Lubahn, D. B.; Carlsten, H.; Dahlman-Wright, K.; Gustafsson, J. A.; Ohlsson, C., Estrogen receptor specificity for the effects of estrogen in ovariectomized mice. J. Endocrinol., 2002, 174, (2), 167-178.
17. Richer, J. K.; Jacobsen, B. M.; Manning, N. G.; Abel, M. G.; Wolf, D. M.; Horwitz, K. B., Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J. Biol. Chem., 2002, 277, (7), 5209-5218.
18. Tora, L.; Gronemeyer, H.; Turcotte, B.; Gaub, M. P.; Chambon, P., The N-terminal region of the chicken progesterone receptor specifies target gene activation. Nature 1988, 333, (6169), 185-188.
19. Gonzalez-Arenas, A.; Villamar-Cruz, O.; Guerra-Araiza, C.; Camacho-Arroyo, I., Regulation of progesterone receptor isoforms expression by sex steroids in the rat lung. J. Steroid Biochem. Mol. Biol., 2003, 85, (1), 25-31.
20. Moser, E. H.; Daxenbichler, G., Detection of a heatand acidstable 'progesterone'-binding protein in the rat lung. FEBS Lett., 1982, 150, (2), 347-353.
21. Camacho-Arroyo, I.; Mendez-Cruz, S. T.; Guerra-Araiza, C.; Cerbon, M. A., Changes in progesterone receptor mRNA content in the rabbit lung during early pregnancy and after sex steroid hormone treatment. J. Endocrinol., 1998, 157, (1), 71-74.
22. Couse, J. F.; Lindzey, J.; Grandien, K.; Gustafsson, J. A.; Korach, K. S., Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse. Endocrinology, 1997, 138, (11), 4613-4621.
23. Saunders, P. T.; Maguire, S. M.; Gaughan, J.; Millar, M. R., Expression of oestrogen receptor beta (ER beta) in multiple rat tissues visualised by immunohistochemistry. J. Endocrinol., 1997, 154, (3), R13-16.
24. Camacho-Arroyo, I.; Gonzalez-Arenas, A.; Gonzalez-Aguero, G.; Guerra-Araiza, C.; Gonzalez-Moran, G., Changes in the content of progesterone receptor isoforms and estrogen receptor alpha in the chick brain during embryonic development. Comp. Biochem. Physio.l A. Mol. Integr. Physiol., 2003, 136, (2), 447-452.
25. Childs, G. V.; Unabia, G.; Komak, S., Differential expression of estradiol receptors alpha and beta by gonadotropes during the estrous cycle. J. Histochem Cytochem, 2001, 49, (5), 665-666.
26. Sharma, S. C.; Clemens, J. W.; Pisarska, M. D.; Richards, J. S., Expression and function of estrogen receptor subtypes in granulosa cells: regulation by estradiol and forskolin. Endocrinology, 1999, 140, (9), 4320-4334.
27. Ilenchuk, T. T.; Walters, M. R., Rat uterine progesterone receptor analyzed by +AFs-3H+AF0-R5020 photoaffinity labeling: evidence that the A and B subunits are not equimolar. Endocrinology, 1987, 120, (4), 1449-1456.
28. Conneely, O. M.; Maxwell, B. L.; Toft, D. O.; Schrader, W. T.; O'Malley, B. W., The A and B forms of the chicken progesterone receptor arise by alternate initiation of translation of a unique mRNA. Biochem. Biophys. Res. Commun., 1987, 149, (2), 493-501.
29. Kastner, P.; Krust, A.; Turcotte, B.; Stropp, U.; Tora, L.; Gronemeyer, H.; Chambon, P., Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. Embo J 1990, 9, (5), 1603-1614.
30. Savouret, J. F.; Bailly, A.; Misrahi, M.; Rauch, C.; Redeuilh, G.; Chauchereau, A.; Milgrom, E., Characterization of the hormone responsive element involved in the regulation of the progesterone receptor gene. Embo. J. 1991, 10, (7), 1875-1883.
31. Nawaz, Z.; Lonard, D. M.; Dennis, A. P.; Smith, C. L.; O'Malley, B. W., Proteasome-dependent degradation of the human estrogen receptor. Proc. Nat. Acad. Sci. U.S.A., 1999, 96, (5), 1858-1862.
32. Gonzalez-Arenas, A.; Neri-Gomez, T.; Guerra-Araiza, C.; Camacho-Arroyo, I., Sexual dimorphism in the content of progesterone and estrogen receptors, and their cofactors in the lung of adult rats. Steroids, 2004, 69, (5), 351-356.
33. Mulac-Jericevic, B.; Mullinax, R. A.; DeMayo, F. J.; Lydon, J. P.; Conneely, O. M., Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. Science, 2000, 289, (5485), 1751-1754.
34. McCabe, T. J.; Roman, L. J.; Masters, B. S., Induction of rabbit lung CYP4A4 prostaglandin omega-hydroxylase by various steroid hormones. Arch. Biochem. Biophys. 2001, 393, (1), 78-86.
35. Takeyama, J.; Suzuki, T.; Inoue, S.; Kaneko, C.; Nagura, H.; Harada, N.; Sasano, H., Expression and cellular localization of estrogen receptors alpha and beta in the human fetus. J. Clin. Endocrinol. Metab. 2001, 86, (5), 2258-2262.
36. Morishige, W. K.; Uetake, C. A., Receptors for androgen and estrogen in the rat lung. Endocrinology, 1978, 102, (6), 1827-1837.
37. Fasco, M. J.; Hurteau, G. J.; Spivack, S. D., Gender-dependent expression of alpha and beta estrogen receptors in human nontumor and tumor lung tissue. Mol. Cell Endocrinol., 2002, 188, (1-2), 125-140.
38. Adamson, I. Y.; King, G. M., Sex differences in development of fetal rat lung. II. Quantitative morphology of epithelialmesenchymal interactions. Lab. Invest, 1984, 50, (4), 461-468.
39. Nielsen, H. C.; Torday, J. S., Sex differences in fetal rabbit pulmonary surfactant production. Pediatr. Res., 1981, 15, (9), 1245-1247.
40. Torday, J. S.; Nielsen, H. C.; Fencl Mde, M.; Avery, M. E., Sex differences in fetal lung maturation. Am. Rev. Respir. Dis., 1981, 123, (2), 205-208.
41. Massaro, D.; Massaro, G. D., Estrogen receptor regulation of pulmonary alveolar dimensions: alveolar sexual dimorphism in mice. Am. J. Physiol. Lung Cell Mol. Physiol., 2006, 290, (5), L866-870.
42. Patrone, C.; Cassel, T. N.; Pettersson, K.; Piao, Y. S.; Cheng, G.; Ciana, P.; Maggi, A.; Warner, M.; Gustafsson, J. A.; Nord, M., Regulation of postnatal lung development and homeostasis by estrogen receptor beta. Mol. Cell Biol., 2003, 23, (23), 8542-8552.
43. Waddell, B. J.; O'Leary, P. C., Distribution and metabolism of topically applied progesterone in a rat model. J. Steroid Biochem. Mol. Biol., 2002, 80, (4-5), 449-455.
44. Carnegie, J. A.; Robertson, H. A., Conjugated and unconjugated estrogens in fetal and maternal fluids of the pregnant ewe: a possible role for estrone sulfate during early pregnancy. Biol. Reprod., 1978, 19, (1), 202-211.
45. Gelly, C.; Sumida, C.; Gulino, A.; Pasqualini, J. R., Concentrations of oestradiol and oestrone in plasma, uterus and other tissues of fetal guinea-pigs: their relationship to uptake and specific binding of +AFs-3H+AF0-oestradiol. J. Endocrinol, 1981, 89, (1), 71-77.
46. Robertson, H. A.; Dwyer, R. J.; King, G. J., Oestrogens in fetal and maternal fluids throughout pregnancy in the pig and comparisons with the ewe and cow. J. Endocrinol., 1985, 106, (3), 355-360.
47. Gross, I.; Wilson, C. M.; Ingleson, L. D.; Brehier, A.; Rooney, S. A., The influence of hormones on the biochemical development of fetal rat lung in organ culture. I. Estrogen. Biochim. Biophys. Acta., 1979, 575, (3), 375-383.
48. Khosla, S. S.; Gobran, L. I.; Rooney, S. A., Stimulation of phosphatidylcholine synthesis by 17 beta-estradiol in fetal rabbit lung. Biochim. Biophys. Acta., 1980, 617, (2), 282-290.
49. Khosla, S. S.; Rooney, S. A., Stimulation of fetal lung surfactant production by administration of 17beta-estradiol to the maternal rabbit. Am. J. Obstet. Gynecol., 1979, 133, (2), 213-216.
50. Khosla, S. S.; Smith, G. J.; Parks, P. A.; Rooney, S. A., Effects of estrogen on fetal rabbit lung maturation: morphological and biochemical studies. Pediatr. Res., 1981, 15, (9), 1274-1281.
51. Possmayer, F.; Casola, P. G.; Chan, F.; MacDonald, P.; Ormseth, M. A.; Wong, T.; Harding, P. G.; Tokmakjian, S., Hormonal induction of pulmonary maturation in the rabbit fetus: effects of maternal treatment with estradiol-17 beta on th endogenous levels of cholinephosphate, CDP-choline and phosphatidylcholine. Biochim. Biophys. Acta., 1981, 664, (1), 10-21.
52. Trotter, A.; Ebsen, M.; Kiossis, E.; Meggle, S.; Kueppers, E.; Beyer, C.; Pohlandt, F.; Maier, L.; Thome, U. H., Prenatal estrogen and progesterone deprivation impairs alveolar formation and fluid clearance in newborn piglets. Pediatr. Res., 2006, 60, (1), 60-64.
53. Matthay, M. A.; Robriquet, L.; Fang, X., Alveolar epithelium: role in lung fluid balance and acute lung injury. Proc. Am. Thorac. Soc., 2005, 2, (3), 206-213.
54. Kemp, P. J.; Kim, K. J., Spectrum of ion channels in alveolar epithelial cells: implications for alveolar fluid balance. Am. J. Physiol. Lung Cell Mol. Physiol., 2004, 287, (3), L460-464.
55. Stutts, M. J.; Canessa, C. M.; Olsen, J. C.; Hamrick, M.; Cohn, J. A.; Rossier, B. C.; Boucher, R. C., CFTR as a cAMP-dependent regulator of sodium channels. Science, 1995, 269, (5225), 847-850.
56. Broackes-Carter, F. C.; Mouchel, N.; Gill, D.; Hyde, S.; Bassett, J.; Harris, A., Temporal regulation of CFTR expression during ovine lung development: implications for CF gene therapy. Hum. Mol. Genet, 2002, 11, (2), 125-131.
57. Sweezey, N.; Tchepichev, S.; Gagnon, S.; Fertuck, K.; O'Brodovich, H., Female gender hormones regulate mRNA levels and function of the rat lung epithelial Na channel. Am. J. Physiol., 1998, 274, (2 Pt 1), C379-386.
58. Massaro, G. D.; Mortola, J. P.; Massaro, D., Sexual dimorphism in the architecture of the lung's gas-exchange region. Proc. Nat. Acad. Sci. U.S.A., 1995, 92, (4), 1105-1107.
59. Carey, M. A.; Card, J. W.; Bradbury, J. A.; Moorman, M. P.; Haykal-Coates, N.; Gavett, S. H.; Graves, J. P.; Walker, V. R.; Flake, G. P.; Voltz, J. W.; Zhu, D.; Jacobs, E. R.; Dakhama, A.; Larsen, G. L.; Loader, J. E.; Gelfand, E. W.; Germolec, D. R.; Korach, K. S.; Zeldin, D. C., Spontaneous airway hyperresponsiveness in estrogen receptor-alpha-deficient mice. Am. J. Respir. Crit. Care Med., 2007, 175, (2), 126-135.
60. McCallister, J. W.; Mastronarde, J. G., Sex differences in asthma. J. Asthma, 2008, 45, (10), 853-861.
61. Postma, D. S., Gender differences in asthma development and progression. Gend. Med., 2007, 4 Suppl B, S133-146.
62. Becklake, M. R.; Kauffmann, F., Gender differences in airway behaviour over the human life span. Thorax 1999, 54, (12), 1119-1138.
63. Osman, M., Therapeutic implications of sex differences in asthma and atopy. Arch. Dis. Child, 2003, 88, (7), 587-590.
64. Siroux, V.; Curt, F.; Oryszczyn, M. P.; Maccario, J.; Kauffmann, F., Role of gender and hormone-related events on IgE, atopy, and eosinophils in the Epidemiological Study on the Genetics and Environment of Asthma, bronchial hyperresponsiveness and atopy. J. Allergy Clin. Immunol., 2004, 114, (3), 491-498.
65. Jeon, Y. H.; Yang, H. J.; Pyun, B. Y., Lung function in Korean adolescent girls: in association with obesity and the menstrual cycle. J. Korean Med. Sci., 2009, 24, (1), 20-25.
66. Costello, L. C.; Hartman, T. E.; Ryu, J. H., High frequency of pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex. Mayo Clin. Proc., 2000, 75, (6), 591-594.
67. Franz, D. N.; Brody, A.; Meyer, C.; Leonard, J.; Chuck, G.; Dabora, S.; Sethuraman, G.; Colby, T. V.; Kwiatkowski, D. J.; McCormack, F. X., Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis. Am. J. Respir. Crit. Care Med., 2001, 164, (4), 661-668.
68. Moss, J.; Avila, N. A.; Barnes, P. M.; Litzenberger, R. A.; Bechtle, J.; Brooks, P. G.; Hedin, C. J.; Hunsberger, S.; Kristof, A. S., Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex. Am. J. Respir. Crit. Care Med., 2001, 164, (4), 669-671.
69. Strizheva, G. D.; Carsillo, T.; Kruger, W. D.; Sullivan, E. J.; Ryu, J. H.; Henske, E. P., The spectrum of mutations in TSC1 and TSC2 in women with tuberous sclerosis and lymphangiomyomatosis. Am J. Respir. Crit. Care Med., 2001, 163, (1), 253-258.
70. Taveira-DaSilva, A. M.; Stylianou, M. P.; Hedin, C. J.; Hathaway, O.; Moss, J., Decline in lung function in patients with lymphangioleiomyomatosis treated with or without progesterone. Chest, 2004, 126, (6), 1867-1874.
71. Caputo, A.; Caci, E.; Ferrera, L.; Pedemonte, N.; Barsanti, C.; Sondo, E.; Pfeffer, U.; Ravazzolo, R.; Zegarra-Moran, O.; Galietta, L. J., TMEM16A, a membrane protein associated with calciumdependent chloride channel activity. Science, 2008, 322, (5901), 590-594.
72. Schroeder, B. C.; Cheng, T.; Jan, Y. N.; Jan, L. Y., Expression cloning of TMEM16A as a calcium-activated chloride channel subunit. Cell, 2008, 134, (6), 1019-1029.
73. Yang, Y. D.; Cho, H.; Koo, J. Y.; Tak, M. H.; Cho, Y.; Shim, W. S.; Park, S. P.; Lee, J.; Lee, B.; Kim, B. M.; Raouf, R.; Shin, Y. K.; Oh, U., TMEM16A confers receptor-activated calcium-dependent chloride conductance. Nature, 2008, 455, (7217), 1210-1215.
74. Coakley, R. D.; Sun, H.; Clunes, L. A.; Rasmussen, J. E.; Stackhouse, J. R.; Okada, S. F.; Fricks, I.; Young, S. L.; Tarran, R., 17beta-Estradiol inhibits Ca2+-dependent homeostasis of airway surface liquid volume in human cystic fibrosis airway epithelia. J. Clin. Invest., 2008, 118, (12), 4025-4035.
75. Fanelli, T.; Cardone, R. A.; Favia, M.; Guerra, L.; Zaccolo, M.; Monterisi, S.; De Santis, T.; Riccardi, S. M.; Reshkin, S. J.; Casavola, V., Beta-oestradiol rescues DeltaF508CFTR functional expression in human cystic fibrosis airway CFBE41o-cells through the up-regulation of NHERF1. Biol. Cell, 2008, 100, (7), 399-412.
76. Ajonuma, L. C.; Tsang, L. L.; Zhang, G. H.; Wong, C. H.; Lau, M. C.; Ho, L. S.; Rowlands, D. K.; Zhou, C. X.; Ng, C. P.; Chen, J.; Xu, P. H.; Zhu, J. X.; Chung, Y. W.; Chan, H. C., Estrogeninduced abnormally high cystic fibrosis transmembrane conductance regulator expression results in ovarian hyperstimulation syndrome. Mol. Endocrinol., 2005, 19, (12), 3038-3044.
77. Rochwerger, L.; Buchwald, M., Stimulation of the cystic fibrosis transmembrane regulator expression by estrogen in vivo. Endocrinology., 1993, 133, (2), 921-930.
78. Goodstadt, L.; Powell, T.; Figtree, G. A., 17beta-estradiol potentiates the cardiac cystic fibrosis transmembrane conductance regulator chloride current in guinea-pig ventricular myocytes. J. Physiol. Sci., 2006, 56, (1), 29-37.
79. Singh, A. K.; Schultz, B. D.; Katzenellenbogen, J. A.; Price, E. M.; Bridges, R. J.; Bradbury, N. A., Estrogen inhibition of cystic fibrosis transmembrane conductance regulator-mediated chloride secretion. J. Pharmacol. Exp. Ther., 2000, 295, (1), 195-204.
80. Zeitlin, P. L., Cystic fibrosis and estrogens: a perfect storm. J Clin Invest 2008, 118, (12), 3841-3844.
81. Dabbs, D. J.; Landreneau, R. J.; Liu, Y.; Raab, S. S.; Maley, R. H.; Tung, M. Y.; Silverman, J. F., Detection of estrogen receptor by immunohistochemistry in pulmonary adenocarcinoma. Ann. Thorac. Surg., 2002, 73, (2), 403-406.
82. Schwartz, A. G.; Prysak, G. M.; Murphy, V.; Lonardo, F.; Pass, H.; Schwartz, J.; Brooks, S., Nuclear estrogen receptor beta in lung cancer: expression and survival differences by sex. Clin. Cancer Res., 2005, 11, (20), 7280-7287.
83. Canver, C. C.; Memoli, V. A.; Vanderveer, P. L.; Dingivan, C. A.; Mentzer, R. M., Jr., Sex hormone receptors in non-small-cell lung cancer in human beings. J. Thorac. Cardiovasc. Surg., 1994, 108, (1), 153-157.
84. Brood-van Zanten, M. M.; Barentsen, R.; van der Mooren, M. J., Hormone replacement therapy and surveillance considerations. Maturitas, 2002, 43 Suppl 1, S57-67.
85. Pritchard, K. I., Hormonal replacement therapy in breast cancer. Ann. Oncol., 2002, 13 Suppl 4, 73-80.
86. Barrett-Connor, E; Stuenkel, C. A., Hormone replacement therapy (HRT)--risks and benefits. Int. J. Epidemiol., 2001, 30, (3), 423-426.
87. Nelson, H. D.; Humphrey, L. L.; Nygren, P.; Teutsch, S. M.; Allan, J. D., Postmenopausal hormone replacement therapy: scientific review. Jama, 2002, 288, (7), 872-881.
88. Genazzani, A. R.; Gadducci, A.; Gambacciani, M., Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. Maturitas, 2001, 40, (2), 117-130.
89. Yager, J. D.; Liehr, J. G., Molecular mechanisms of estrogen carcinogenesis. Ann. Rev. Pharmacol. Toxicol., 1996, 36, 203-232.
90. Dupont, W. D.; Page, D. L., Menopausal estrogen replacement therapy and breast cancer. Arch. Intern. Med., 1991, 151, (1), 67-72.
91. Newcomb, P. A.; Longnecker, M. P.; Storer, B. E.; Mittendorf, R.; Baron, J.; Clapp, R. W.; Bogdan, G.; Willett, W. C., Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women. Am. J. Epidemiol., 1995, 142, (8), 788-795.
92. Stanford, J. L.; Weiss, N. S.; Voigt, L. F.; Daling, J. R.; Habel, L. A.; Rossing, M. A., Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middleaged women. Jama, 1995, 274, (2), 137-142.
93. Wingo, P. A.; Layde, P. M.; Lee, N. C.; Rubin, G.; Ory, H. W., The risk of breast cancer in postmenopausal women who have used estrogen replacement therapy. Jama, 1987, 257, (2), 209-215.
94. Taioli, E.; Wynder, E. L., Re: Endocrine factors and adenocarcinoma of the lung in women. J. Nat. Cancer Inst., 1994, 86, (11), 869-870.
95. Wu, A. H.; Yu, M. C.; Thomas, D. C.; Pike, M. C.; Henderson, B. E., Personal and family history of lung disease as risk factors for adenocarcinoma of the lung. Cancer Res., 1988, 48, (24 Pt 1), 7279-7284.
96. Ettinger, B.; Friedman, G. D.; Bush, T.; Quesenberry, C. P., Jr., Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet. Gynecol., 1996, 87, (1), 6-12.
97. Kreuzer, M.; Gerken, M.; Heinrich, J.; Kreienbrock, L.; Wichmann, H. E., Hormonal factors and risk of lung cancer among women? Int. J. Epidemiol., 2003, 32, (2), 263-271.
98. Olsson, H.; Bladstrom, A.; Ingvar, C., Are smoking-associated cancers prevented or postponed in women using hormone replacement therapy? Obstet. Gynecol., 2003, 102, (3), 565-570.
99. Schabath, M. B.; Wu, X.; Vassilopoulou-Sellin, R.; Vaporciyan, A. A.; Spitz, M. R., Hormone replacement therapy and lung cancer risk: a case-control analysis. Clin. Cancer Res., 2004, 10, (1 Pt 1), 113-123.
100. Beral, V.; Hermon, C.; Kay, C.; Hannaford, P; Darby, S.; Reeves, G., Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46 000 women from Royal College of General Practitioners' oral contraception study. Bmj, 1999, 318, (7176), 96-100.
101. Colditz, G. A., Oral contraceptive use and mortality during 12 years of follow-up: the Nurses' Health Study. Ann Intern Med 1994, 120, (10), 821-826.
102. Kumle, M.; Alsaker, E.; Lund, E., +AFs-Use of oral contraceptives and risk of cancer, a cohort study+AF0-. Tidsskr Nor Laegeforen, 2003, 123, (12), 1653-1666.
103. Beral, V.; Hannaford, P.; Kay, C., Oral contraceptive use and malignancies of the genital tract. Results from the Royal College of General Practitioners' Oral Contraception Study. Lancet, 1988, 2, (8624), 1331-1335.
104. Hannaford, P. C.; Selvaraj, S.; Elliott, A. M.; Angus, V.; Iversen, L.; Lee, A. J., Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner's oral contraception study. Bmj, 2007, 335, (7621), 651.